All blog posts
Total 12 results for
Showing 12 out of 12 results
03 March 2025
Latest CRTea podcast now available: Navigating competition law and FDI regulation in the pharmaceuticals sector - 2025 Outlook
23 December 2024
Le Patourel v BT - First competition class action to go to trial fails: key takeaways and implications for the regime
14 October 2024
Highlights from the GCR Live: Competition Litigation conference
21 December 2023
Clarity: Over the Hills and (F)Far Away? The FIFA Football Agents Regulations and their interplay with competition law
06 December 2023
Competition law and biosimilars: Time for a new approach or not yet?
15 August 2023
CAT upholds CMA excessive pricing decision in liothyronine tablets case
25 April 2022
Wide ranging reforms to UK competition and consumer protection regimes unveiled
23 July 2021
UK government proposes wide ranging reforms to its competition and consumer protection regimes
16 February 2021
Excessive pricing: EU Commission accepts Aspen’s drug pricing commitments
27 January 2021
Metal trader requests fast-track competition infringement claim against leading trade association
30 March 2020
The impact of COVID-19 on competition law in the pharmaceutical sector
13 March 2020
UK Court of Appeal refuses to reinstate excessive pricing fines in key pharma case
Showing 12 out of 12 results
Key contacts
Kyriakos Fountoukakos
Managing Partner, Competition Regulation and Trade, Brussels
Veronica Roberts
Partner, UK Regional Head of Practice, Competition, Regulation and Trade, London
Linda Evans
Regional Head of Practice – Competition, Regulation and Trade, Australia, Sydney
